Multiomics has moved from buzzword to budget line — and instrument vendors are taking notice. From new mass spec platforms at ASMS 2026 to sequencing chemistries at AGBT, the race is on to own the…

As regulators accelerate the phase-out of animal testing, New Approach Methodologies are moving from policy to practice — and reshaping which neuroscience instruments, readouts, and workflows matter most.

SDi analysts cover the key findings from the 2026 Global Assessment Report — market sizing, five-year forecasts, vendor rankings, and competitive trends across 80+ instrument technologies. Free. On demand. 30 minutes.

In vivo CAR-T is moving from concept to clinic and it’s redistributing analytical instrument demand in ways OEMs can’t afford to miss. SDi maps where the opportunity is shifting.

The push toward real‑time verification and pre‑analytical quality control was visible across SLAS 2026, reflected in new on‑deck sensing modules and instrumentation designed to validate runs as they occur in real-time. The full extent of new products and themes was…